The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...

Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...

today announced an upcoming poster for bezuclastinib at the 2025 American Academy of Allergy Asthma & Immunology Annual Meeting (AAAAI) being held in San Diego, CA, February 28-March 3 ...

These findings were presented on March 1 on an AAAAI poster and published the day before in JAMA Network Open. “We expected Black children to be at increased risk for asthma, but I thought that ...

The team reported preliminary results at a February 28 AAAAI poster session. During the 2023-2024 school year, stock inhalers were used at school 124 times — 120 times for asthma symptoms and 4 ...

Recently presented THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU) Strategic alternatives process underway to maximize value creation across ...

Please come by our poster if you are attending AAAAI. If not, reach out if you would like a copy. Subcutaneous immunoglobulin is effective in IG naiive patients!

LAOAG CITY — The Commission on Elections (Comelec) 1 (Ilocos Norte) gave local candidates three days to take down their oversized and illegally placed campaign posters across the province. The poll ...